Beckman Coulter Diagnostics appoints Catherine Jennings as president
DHR•Danaher unit Beckman Coulter Diagnostics appointed Catherine “Cat” Jennings as president; she joins from Boston Scientific, where she led a business with about $2 billion in annual revenue.
1. Leadership appointment
Jennings will oversee strategy and operations, with a mandate to accelerate innovation and expand global reach in clinical diagnostics. She previously led Boston Scientific’s Vascular Therapies business, which had about $2 billion in annual revenue.
